NuVasive Receives Premarket Approval of Cervical Spine Disc System

Spinal Tech

NuVasive has received premarket approval of its PCM Cervical Disc System from the FDA. The PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7. The device is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment prior to implantation.

More Articles on Orthopedic Devices:

New Instrumentation & Partnership for DePuy Synthes Spine
DePuy Synthes Spine Launches Minimally Invasive Posterior-Lateral Fusion System
10 Orthopedic Device Company Acquisitions

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers